Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Mouth Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Lobular 1

Interventions

pembrolizumab 4Cyclophosphamide 4Radiotherapy 3Cisplatin 3fludarabine 2Doxorubicin 2Carboplatin 2zimberelimab 1olaparib 1lenvatinib 1envafolimab 1avelumab 1Thymectomy 1Taxes 1Sunitinib 1Robotic Surgical Procedures 1Ramucirumab 1Radiotherapy, Adjuvant 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Etoposide 1Drug Therapy 1Chemoradiotherapy 1Cetuximab 1AP 1903 reagent 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Radiotherapy, Adjuvant × 1 year × Clear all
NCT02633553 2026-04-24

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Fudan University

Phase NA Recruiting
238 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡